NASDAQ · Biotechnology

Conexeu Sciences Inc. (CNXU) Stock

$3.89 +12.75% NASDAQ: CNXU Healthcare

Conexeu Sciences Inc. specializes in pioneering regenerative biomaterials intended for various medical fields, including wound management, dental practices, and aesthetic medicine.

Valuation

MetricValue
Price$3.89
Market Cap$104.09M
P/E Ratio-9.38
P/B Ratio12.97
P/S Ratio—
EPS (TTM)$-0.53
52-Week High$18.79
52-Week Low$3.05
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE—
ROA—
ROCE—
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity0.00
Current Ratio7.89

Latest News

A $190 Billion Weight-Loss Boom Has Exposed a Tissue-Restoration Gap Today’s Injectables Were Not Built to Fill GlobeNewswire · Jul 7, 2026 Conexeu Sciences Opens Vancouver R&D Facility to Advance Regenerative Tissue Platform GlobeNewswire · Jun 25, 2026 Is Conexeu Sciences (CNXU) Quietly Redefining Its Commercial Ambitions With CXU Platform Moves? Simply Wall St. · Jun 19, 2026 Conexeu Expands Board, Executive, and Advisory Leadership With Five Appointments Post Nasdaq Listing GlobeNewswire · Jun 15, 2026 Conexeu Sciences Reports Manufacturing Scale Up and Regulatory Progress for Lead CXU™ Wound Care Program GlobeNewswire · Jun 8, 2026

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA-16.44
FCF Yield—
Quick Ratio6.83
Interest Coverage—
Return 1Y—
Return 3Y—
Return 5Y—

Ownership

Insiders Held40.98%
Institutions Held0.00%
Institutions Float Held0.00%

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $336.64 -1.11% 38.93 $4.94T 0.32%
MSFTMicrosoft Corporation $535.07 +2.38% 28.68 $3.97T 0.76%
GOOGLAlphabet Inc. $351.66 +0.97% 16.94 $4.26T 0.26%
AMZNAmazon.com, Inc. $262.43 +3.29% 19.82 $2.82T 0.00%
METAMeta Platforms, Inc. $718.67 -0.31% 27.93 $1.83T 0.28%

About Conexeu Sciences Inc.

Conexeu Sciences Inc. specializes in pioneering regenerative biomaterials intended for various medical fields, including wound management, dental practices, and aesthetic medicine. The enterprise began operations on November 2, 2022, co-founded by Claudia Chavez-Munoz, David R. Bogart, and Ryan Hartwell, and operates from its primary office in Reno, Nevada.

Conexeu Sciences Inc. is led by CEO Miles Harrison, employs 4 people, headquartered in US, publicly traded since 2026.

Conexeu Sciences Inc. (CNXU) stock trades at $3.89 with a market capitalization of $104.09M. The stock is valued at a price-to-earnings (P/E) ratio of -9.38, price-to-book of 12.97. Over the past 52 weeks the stock has ranged between $3.05 and $18.79, and currently trades 79.3% below its 52-week high.

On profitability, Conexeu Sciences Inc. generates an operating margin of 0.00%, a net profit margin of 0.00%.

Official website: www.conexeu.com

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.20 +0.26% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides